Blood cancers dominate CAR-T pipeline: GlobalData EP News Bureau Mar 21, 2025 According to GlobalData’s Drugs Database, blood cancers account for over half of all CAR-Ts in the active pipeline* and make up…
US FDA approves Gilead cell therapy for earlier lymphoma Reuters Apr 4, 2022 The one-time treatment was initially approved in 2017 for patients with large B-cell lymphoma who did not respond to at least two…
Kite gets US FDA nod for Yescarta to treat relapsed or refractory follicular lymphoma EP News Bureau Mar 6, 2021 Yescarta is the first CAR T-Cell therapy approved for indolent follicular lymphoma
